Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent
Xconomy
AUGUST 17, 2016
San Diego’s Avelas Biosciences , founded in 2009 to advance a fluorescing biologic agent intended to help surgeons differentiate cancerous tissue from healthy tissue, has completed a $20 million Series C round of venture funding. and San Diego’s Avalon Ventures. The company also is planning to relocate to new offices, Stengone said.
Let's personalize your content